Treatment of Established Lesions Caused by High-risk Human Papilloma Virus Using a Synthetic Vaccine

Author(s):
Melief, C.J.M.
Published
2012
Publication type
Article / Letter to editor
human papilloma virus type 16 (HPV16)cancer vaccinesynthetic vaccinepeptide vaccineT lymphocyteCD4 T cellCD8 T cellvulvar intraepithelial neoplasia (VIN)Montanide ISA-51
Date issued
2012-04-30
Language
English
Is part of
Journal of Immunotherapy (2012), Vol. 35, no. 3, p. 215-216
hdl
1887/106396
doi
10.1097/CJI.0b013e318248f17f